Nanomaterials in the Pharmaceuticals: Occurrence, Behaviour and Applications
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
1472-1484
Author(s):
Imran Uddin, Siddarthan Venkatachalam, Arka Mukhopadhyay and Mohd Amil Usmani
Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
455-463
Author(s):
Hamed Mirzaei, Amirhossein Sahebkar, Amir Avan, Mahmoud R. Jaafari, Rasoul Salehi, Hossein Salehi, Hossein Baharvand, Abbas Rezaei, Jamshid Hadjati, John M. Pawelek and Hamid R. Mirzaei
Updates on the Production of Therapeutic Antibodies Using Human Hybridoma Technique
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
870-878
Author(s):
Xenia A. Glukhova, Olga V. Prusakova, Julia A. Trizna, Michael M. Zaripov, Gaida V. Afanas’eva, Anatoly S. Glukhov, Rimma A. Poltavtseva, Alexei A. Ivanov, Marco Avila-Rodriguez, George E. Barreto, Gjumrakch Aliev and Igor P. Beletsky
Molecular Approach to Targeted Therapy for Multiple Sclerosis
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
15
Page:
20-34
Author(s):
Gajanan V. Sherbet
Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors
Journal:
Current Drug Metabolism
Volume:
17
Page:
118-128
Author(s):
Lisi Qi, Yuanyuan Guo, Pei Zhang, Xiaorong Cao and Yuxia Luan
Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Journal:
Current Biotechnology
Volume:
4
Page:
319-344
Author(s):
Meerza Abdul Razak, Shankarappa Devi Prasad Boggupalli and Buddolla Viswanath
Therapy Stratifications and Novel Approach in Pursuit of Aids Related Kaposi’s Sarcoma Management- A paradigm for Non Invasiveness
Journal:
Current Drug Delivery
Volume:
12
Page:
770-781
Author(s):
Meenu Sharma, Vijay Sharma and Kamla Pathak
The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Journal:
Current Drug Targets
Volume:
17
Page:
76-110
Author(s):
Daniela Angela Covino, Michela Sabbatucci and Laura Fantuzzi
HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET
Journal:
Current Drug Targets
Volume:
17
Page:
33-45
Author(s):
Chiara Chiozzini and Elena Toschi
Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
Journal:
Current Drug Targets
Volume:
17
Page:
54-64
Author(s):
Erica Giuliani, Lia Vassena, Cristina Cerboni and Margherita Doria